Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,911
Total Claims
$1.0M
Drug Cost
823
Beneficiaries
$1,221
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+97%
Opioid rate vs peers
5.1% vs 2.6% avg
+14%
Cost per patient vs peers
$1,221 vs $1,068 avg
+9%
Brand preference vs peers
9.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.1%
Opioid Rate
756
Opioid Claims
$20K
Opioid Cost
8.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,448 claims · $745K
Generic: 13,342 claims · $255K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 117 | $102K |
| Sitagliptin Phosphate | 82 | $84K |
| Semaglutide | 51 | $72K |
| Dulaglutide | 44 | $56K |
| Apixaban | 51 | $43K |
| Budesonide/Formoterol Fumarate | 63 | $38K |
| Denosumab | 18 | $31K |
| Linaclotide | 23 | $25K |
| Fluticasone Propion/Salmeterol | 45 | $24K |
| Rivaroxaban | 21 | $19K |
| Sitagliptin Phos/Metformin Hcl | 17 | $18K |
| Fluticasone/Umeclidin/Vilanter | 19 | $17K |
| Insulin Aspart | 16 | $17K |
| Tirzepatide | 15 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $16K |
Prescribing Profile
Patient Profile
71
Avg Age
79%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About